Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Cross Country Healthcare, Inc. before investing.
In this article, we go over a few key elements for understanding Cross Country Healthcare, Inc.’s stock price such as:
- Cross Country Healthcare, Inc.’s current stock price and volume
- Why Cross Country Healthcare, Inc.’s stock price changed recently
- Upgrades and downgrades for CCRN from analysts
- CCRN’s stock price momentum as measured by its relative strength
About Cross Country Healthcare, Inc. (CCRN)
Before we jump into Cross Country Healthcare, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
Cross Country Healthcare, Inc. is a technology-enabled workforce solution and advisory company. It operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs (MSP); education healthcare services; in-home care services; and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, government facilities and managed care organizations.
Want to learn more about Cross Country Healthcare, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Cross Country Healthcare, Inc..
Cross Country Healthcare, Inc.’s Stock Price as of Market Close
As of August 12, 2024, 4:00 PM, CST, Cross Country Healthcare, Inc.’s stock price was $14.31.
Cross Country Healthcare, Inc. is down 6.35% from its previous closing price of $15.28.
During the last market session, Cross Country Healthcare, Inc.’s stock traded between $14.98 and $15.79. Currently, there are 33.96 million shares of Cross Country Healthcare, Inc. stock available for purchase.
Cross Country Healthcare, Inc.’s price-earnings (P/E) ratio is currently at 66.3, which is high compared to the Employment Services industry median of 21. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
Cross Country Healthcare, Inc. Stock Price History
Cross Country Healthcare, Inc.’s (CCRN) price is currently down 21.55% so far this month.
During the month of August, Cross Country Healthcare, Inc.’s stock price has reached a high of $18.24 and a low of $14.24.
Over the last year, Cross Country Healthcare, Inc. has hit prices as high as $26.17 and as low as $12.87. Year to date, Cross Country Healthcare, Inc.’s stock is down 46.14%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Cross Country Healthcare, Inc. Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 09, 2024, there were 8 analysts who downgraded Cross Country Healthcare, Inc.’s stock and 0 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Cross Country Healthcare, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Cross Country Healthcare, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Cross Country Healthcare, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Cross Country Healthcare, Inc. (CCRN) by visiting AAII Stock Evaluator.
Relative Price Strength of Cross Country Healthcare, Inc.
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of August 09, 2024, Cross Country Healthcare, Inc. has a weighted four-quarter relative price strength of -10.50%, which translates to a Momentum Score of 32 and is considered to be Weak.
Want to learn more about how Cross Country Healthcare, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Cross Country Healthcare, Inc. Stock Price: Bottom Line
As of August 12, 2024, Cross Country Healthcare, Inc.’s stock price is $14.31, which is down 6.35% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Cross Country Healthcare, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Yield Screen: 8.7% Compared to S&P 500
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.